|
Market Closed -
Nasdaq
01:30:00 27/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.5133 USD | -1.16% |
|
+4.12% | -67.51% |
| 12/10 | Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. | CI |
| 09/10 | Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer | MT |
| Market Cap | 12Cr 11Cr 10Cr 9.36Cr 18Cr 1.19TCr 18Cr 124.4Cr 49Cr 621.83Cr 47Cr 46Cr 1.97TCr | P/E 2026 * |
-0.89x | P/E 2027 * | -2.37x |
|---|---|---|---|---|---|
| Enterprise Value | 12Cr 11Cr 10Cr 9.36Cr 18Cr 1.19TCr 18Cr 124.4Cr 49Cr 621.83Cr 47Cr 46Cr 1.97TCr | EV / Sales 2026 * |
183x | EV / Sales 2027 * | 2.84x |
| Free-Float |
86.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OTLK | Delayed | |
CBOE
| OTLK | Real-time | |
|
Deutsche Boerse AG
| 41O | Delayed | |
|
Tradegate
| 41O | Real-time | |
|
Börse Stuttgart
| 41O | Delayed | |
|
Boerse Muenchen
| 41O | Real-time | |
|
Xetra
| 41O | Delayed |
Last Transcript: Outlook Therapeutics, Inc.
| 1 day | -1.16% | ||
| 1 week | +4.12% | ||
| Current month | -10.50% | ||
| 1 month | -19.73% | ||
| 3 months | -63.47% | ||
| 6 months | +62.90% | ||
| Current year | -67.51% |
| 1 week | 0.49 |  | 0.6 |
| 1 month | 0.44 | | 0.64 |
| Current year | 0.16 | | 1.88 |
| 1 year | 0.16 | | 2.54 |
| 3 years | 0.16 | | 13.32 |
| 5 years | 0.16 | | 43.3 |
| 10 years | 0.16 | | 699.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jahr
CEO | Chief Executive Officer | 54 | 01/07/2025 |
Kevin Lundquist
DFI | Director of Finance/CFO | 58 | 01/09/2026 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
BRD | Director/Board Member | 65 | 11/12/2015 |
| Chairman | 41 | 31/01/2025 | |
Yazan Haddadin
BRD | Director/Board Member | 50 | 31/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Free | Chief Financial Officer | 5,00,000 | 0.3122% | ||
| 14/08/26 | Buy | Chief Executive Officer | 2,02,020 | 0.0832% | ||
| 14/08/26 | Buy | Chief Executive Officer | 3,03,030 | 0.1249% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | +4.12% | -63.07% | -95.19% | 12Cr | |
| +0.88% | -0.34% | +40.64% | +73.05% | 6.53TCr | |
| -0.18% | -0.18% | +9.60% | +77.16% | 5.46TCr | |
| -0.66% | +0.96% | +9.06% | +100.57% | 5.36TCr | |
| -2.06% | +2.90% | +24.07% | +48.36% | 4.5TCr | |
| -1.79% | +0.19% | +19.32% | +123.62% | 4.22TCr | |
| -1.65% | +0.96% | +237.56% | +823.66% | 3.94TCr | |
| -2.26% | -4.14% | +15.38% | +45.53% | 3.27TCr | |
| -2.70% | -10.77% | +19.80% | -6.47% | 2.4TCr | |
| +0.25% | +14.76% | +59.68% | +48.78% | 2.65TCr | |
| Average | -1.12% | +2.56% | +37.20% | +123.91% | 3.83TCr | |
| Weighted average by Cap. | -0.91% | +2.27% | +45.58% | +148.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7L 6L 6L 5L 10L 6.49Cr 10L 67.96L 26.88L 3.4Cr 25.62L 25.07L 11Cr | 4.41Cr 3.94Cr 3.65Cr 3.3Cr 6.18Cr 419.29Cr 6.28Cr 44Cr 17Cr 219.3Cr 17Cr 16Cr 694.37Cr |
| Net income | -6.51Cr -5.82Cr -5.39Cr -4.88Cr -9.13Cr -619.36Cr -9.28Cr -65Cr -26Cr -323.95Cr -24Cr -24Cr -1.03TCr | -4.44Cr -3.97Cr -3.68Cr -3.33Cr -6.23Cr -422.74Cr -6.33Cr -44Cr -17Cr -221.11Cr -17Cr -16Cr -700.09Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | $0.5133 | -1.16% | 25,29,683 |
| 23/26/23 | $0.5193 | -7.84% | 30,82,822 |
| 22/26/22 | $0.5635 | +0.39% | 43,95,784 |
| 21/26/21 | $0.5613 | +7.94% | 29,96,944 |
| 20/26/20 | $0.5200 | +5.48% | 33,11,830 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OTLK Stock
Select your edition
All financial news and data tailored to specific country editions
